BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Liver, Human chorionic gonadotropin, Lovastatin, rs2476601, BRAF, Apoptosis, Leukemia)
Bookmark Forward

QuickView for regulation of oligodendrocyte progenitor proliferation (biogroup)


Body Atlas

Most Correlated Tissues

  1. Pons
  2. Nodose nucleus
  3. Hypothalamus
  4. Corpus callosum
  5. Globus pallidus
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Vesicular stomatitis Indiana virus disease
  2. 11p partial monosomy syndrome
  3. Helicobacter pylori gastrointestinal tract infection
  4. Anthrax
  5. Injury of external ear
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CGP 60474
  2. A 443654
  3. flavopiridol
  4. CYT 387
  5. AZD1480
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIRLET7I
  2. SULF1
  3. SMN2
  4. RORB
  5. PPP2R2C
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
  2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  5. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferat…
  2. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the di…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With …
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.